Headlands Technologies’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-9,652	Closed	-$44.6K	–	1224
2024 Q2	$44.6K	Buy	+9,652	New	+$44.6K	﹤0.01%	790
2024 Q1	–	Sell	-6,880	Closed	-$38.9K	–	1273
2023 Q4	$38.9K	Buy	+6,880	New	+$38.9K	0.01%	568